Can new criteria for impaired fasting glucose (IFG) replace oral glucose testing (OGT) for cystic fibrosis-related diabetes (CFRD)? Source: Eur Respir J 2004; 24: Suppl. 48, 616s Year: 2004
Longitudinal follow-up of pulmonary, nutritional and laboratory data in patients with cystic fibrosis related diabetes mellitus (CFRD) after initial treatment with glibenclamid Source: Eur Respir J 2003; 22: Suppl. 45, 229s Year: 2003
Glucose tolerance, beta-cell function and insulin sensitivity in cystic fibrosis patients awaiting lung transplantation Source: Eur Respir J 2006; 28: Suppl. 50, 780s Year: 2006
Metabolic syndrome and diabetes mellitus in COPD Source: Eur Respir Mon 2013; 59: 117-134 Year: 2013
Peculiarities of diabetes mellitus in cystic fibrosis adults Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010
Increased augmentation index in patients with cystic fibrosis Source: Eur Respir J 2009; 34: 1322-1328 Year: 2009
The association of pulmonary fibrosis with diabetes mellitus Source: ERJ Open Res, 6 (4) 00237-2020; 10.1183/23120541.00237-2020 Year: 2020
Inadequate glucose control in type 2 diabetes is associated with impaired lung function and with systemic inflammation Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009
Lung function and early abnormality of glucose tolerance (GT) in cystic fibrosis (CF) patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013
Cystic fibrosis related diabetes (CFRD) and diabetic control as a determinant of pulmonary function: fact or fiction? Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health Year: 2008
Impact of flash glucose monitoring system in cystic Fibrosis related diabetes Source: Virtual Congress 2020 – Cystic fibrosis Year: 2020
Improving identification and treatment of children & adolescents with cystic fibrosis related diabetes (CFRD) Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems Year: 2012
The conjunctival microcirculation disturbances at COPD patients in combination with diabetes mellitus type 2 and their correction by gliclazide Source: Eur Respir J 2004; 24: Suppl. 48, 61s Year: 2004
Effect of inhaled human insulin (EXUBERA®; EXU) vs subcutaneous insulin (SC) on lung lining fluid constituents in adults with type 1 diabetes mellitus (T1DM) Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology II Year: 2007
Study of pulmonary function in type2 diabetes mellitus and its changes with change in duration and glycemic control Source: Annual Congress 2012 - Pathophysiological mechanisms in disease: new insights Year: 2012
Elevated breath glucose is related to respiratory symptoms and not to disease type, control, duration or complications in diabetes mellitus patients Source: Eur Respir J 2007; 30: Suppl. 51, 365s Year: 2007
Screening for diabetes mellitus in patients with OSAS: a case for glycosylated haemoglobin Source: Eur Respir J 2012; 40: 273-274 Year: 2012
Exercise tolerance in adults with cystic fibrosis Source: Annual Congress 2008 - Cystic fibrosis: a disease with many aspects Year: 2008
Inhaled insulin does not induce immediate airway responsiveness in patients with type 1 diabetes mellitus Source: Eur Respir J 2005; 26: Suppl. 49, 582s Year: 2005
Peripheral insulin resistance accounts for impaired glucose tolerance and is associated with systemic inflammation in COPD Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011